Physician profile
Karen M Helland
NPI 1255448205
$914.65
in general payments reported to CMS, 2019-2025
16 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.41 · 2022: $77.54 · 2023: $293 · 2024: $230 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $134.83 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $127.80 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $110.67 | 2023-2024 | |
| Inspire Medical Systems, INC. | $99.55 | 2025 | Inspire |
| Boston Scientific Corporation | $66.49 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $62.29 | 2021-2024 | |
| Glaxosmithkline, LLC. | $54.36 | 2023-2024 | Shingrix, Arexvy |
| Exact Sciences Corporation | $54.26 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $44.60 | 2024-2025 | Repatha, Otezla, Repatha |
| Medtronic, INC. | $31.34 | 2023 | Venaseal |
| Dynavax Technologies Corporation | $30.93 | 2023 | Heplisav-B |
| Merck Sharp & Dohme LLC | $28.76 | 2021-2025 | Lagevrio |
| Viiv Healthcare Company | $20.61 | 2022 | |
| Impel Pharmaceuticals INC. | $17.80 | 2023 | Trudhesa |
| Esperion Therapeutics, INC. | $16.28 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.08 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Helland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.